Diabetologia
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Identification of PAM as a novel monogenic diabetes gene
2023
-
Waist-to-hip ratio is a stronger, more consistent predictor of all-cause mortality than BMI
2022
-
Validation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trial
2022
-
Gender differences in cardiovascular risk, treatment, and outcomes: a post-hoc analysis from the REWIND trial
2021
-
Remission of type 2 diabetes following a short-term intervention with insulin glargine and metformin/sitagliptin: results of the REMIT-sita randomised controlled trial
2021
-
Remission of type 2 diabetes following intensive treatment with insulin glargine/lixisenatide, metformin and lifestyle approaches: results of the REMIT-iGlarLixi trial
2021
-
Cardio protection with dulaglutide is not depending on baseline therapy with metformin: a subgroup analysis of the REWIND trial
2020
-
Cardiovascular outcomes in patients with type 2 diabetes and reduced eGFR and albuminuria: a REWIND post hoc subgroup analysis
2020
-
Dulaglutide reduces HbA(1c) irrespective of antihyperglycaemic agents, duration of diabetes, BMI and weight loss: a post hoc analysis from the REWIND trial
2020
-
Effect of dulaglutide on kidney function-related outcomes in type 2 diabetes: post hoc analysis from the REWIND trial
2020
-
Effects of intensive risk factor management on cardiovascular autonomic neuropathy in type 2 diabetes: findings from the ACCORD clinical trial
2020
-
Exploring potential mediators of the cardiovascular benefit of dulaglutide in REWIND
2020
-
Angiotensin-converting enzyme and type 2 diabetes risk: a Mendelian randomisation study
2019
-
CD-DIET: a randomised controlled study to assess treatment of asymptomatic coeliac disease and type 1 diabetes on glycaemic control and variability in adults and children
2019
-
Diabetes regression and remission following a short-term intensive metabolic intervention with insulin glargine, metformin and dapagliflozin
2019
-
Genome-wide polygenic risk scores and prediction of gestational diabetes in South Asian women
2019
-
Gut microbiota during obesity is sufficient to impair insulin clearance in mice
2019
-
Novel biomarkers predicting renal decline in people with dysglycaemia in the ORIGIN trial
2019
-
Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)
2018
-
The incretin effect of essential amino acids (EAA) in youth and ageing
2018
-
Early remission and later progression of type 2 diabetes after gastric bypass are related to changes in intestinal glucose transport
2017
-
IGFBP-3 is a marker of impaired adipose tissue function and a novel causal mediator of type 2 diabetes risk: a report from the ORIGIN study
2017
-
Novel biomarkers predicting heart failure hospitalisation in people with dysglycaemia in the ORIGIN trial
2017
-
Effects of lixisenatide on natriuretic peptides in patients with diabetes and acute coronary syndrome
2016
-
Novel biomarkers predicting a microvascular composite outcome in people with dysglycaemia in the ORIGIN trial
2016
-
Performance of the validated ORIGIN cardiovascular biomarker panel in HOPE study participants with diabetes
2016
-
Diet interacts with host NOD2 genotype to control blood glucose and the gut microbiota
2015
-
Increased risk of cardiovascular-related events associated with sulfonylureas compared to other antihyperglycaemic drugs: a Bayesian meta-analysis of survival data
2015
-
Outcome reduction with an initial glargine intervention and legacy effects (ORIGINALE)
2014
-
Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial
2011
-
Physician-patient ethnic concordance improves diabetes care for ethnic minority patients
2010
-
Ethnic disparities in eye care for people with diabetes
2009
-
Once-daily insulin glargine requires a significantly lower dose than insulin detemir twice daily to achieve good glycaemic control in patients with type 2 diabetes failing oral therapy
2009
-
Whole 24-hour continuous glucose monitoring profiles with insulin glargine or oral antidiabetic drug therapy in patients with type 2 diabetes mellitus
2008
-
Efficacy of a novel CB1 antagonist, GRC 10801, in improving glucose tolerance in combination with known antidiabetic drugs
2007
-
NNOS is necessary for normal increases in glucose uptake during contraction of skeletal muscle
2007
-
Diabetes status and fasting plasma glucose are independent determinants of cognitive status in people at high risk for cardiovascular disease
2006
-
Efficacy and safety of glargine insulin in primary care
2005
-
Glucose control during early insulinization with glargine as assessed by the continuous glucose monitoring system (CGMS)
2005
-
The efficacy and safety of acarbose in the treatment of type 2 diabetes mellitus in elderly patients.
1999
-
Balance of islet cell birth and death of fetal and neonatal rats is altered by a low protein diet through mechanisms which include cell cycle kinetics
1998
-
BETA-CYTOTOXIC FLUORESCENCE MARKERS OF SULFHYDRYL-GROUPS AS TOOLS FOR THE INVESTIGATION OF INSULIN RELEASE
1981
-
HUMAN PANCREATIC POLYPEPTIDE (HPP) PLASMA CONCENTRATIONS IN FASTING HUMAN INFANTS AND ADULTS
1978
-
Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review.
67:443-458.
2024
-
Identifying blood biomarkers for type 2 diabetes subtyping: a report from the ORIGIN trial.
66:1045-1051.
2023
-
Urban–rural disparities in diabetes-related mortality in the USA 1999–2019.
65:2078-2083.
2022
-
Exploring ethnic representativeness in diabetes clinical trial enrolment from 2000 to 2020: a chronological survey.
65:1461-1472.
2022
-
Obesity in late adolescence and incident type 1 diabetes in young adulthood.
65:1473-1482.
2022
-
Consensus report: Definition and interpretation of remission in type 2 diabetes.
39:e14669.
2022
-
Consensus report: definition and interpretation of remission in type 2 diabetes.
64:2359-2366.
2021
-
Normal to enhanced intrinsic mitochondrial respiration in skeletal muscle of middle- to older-aged women and men with uncomplicated type 1 diabetes.
64:2517-2533.
2021
-
Diabetes induces dysregulation of microRNAs associated with survival, proliferation and self-renewal in cardiac progenitor cells.
64:1422-1435.
2021
-
Correction to: Altered mitochondrial bioenergetics and ultrastructure in the skeletal muscle of young adults with type 1 diabetes.
63:887-888.
2020
-
Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial.
62:549-552.
2019
-
Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial.
61:1734-1747.
2018
-
Altered mitochondrial bioenergetics and ultrastructure in the skeletal muscle of young adults with type 1 diabetes.
61:1411-1423.
2018
-
Meta-genome-wide association studies identify a locus on chromosome 1 and multiple variants in the MHC region for serum C-peptide in type 1 diabetes.
61:1098-1111.
2018
-
ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial.
60:69-80.
2017
-
Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts.
58:87-97.
2015
-
Does genetic heterogeneity account for the divergent risk of type 2 diabetes in South Asian and white European populations?.
57:2270-2281.
2014
-
Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial.
57:2030-2037.
2014
-
Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies.
57:2019-2029.
2014
-
AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice.
57:1693-1702.
2014
-
Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial.
57:1325-1331.
2014
-
Variation at the DPP4 locus influences apolipoprotein B levels in South Asians and exhibits heterogeneity in Europeans related to BMI.
57:738-745.
2014
-
Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy.
56:2068-2077.
2013
-
Setting the record straight on TIDE: a lost opportunity for patients with diabetes.
56:1884-1887.
2013
-
Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative.
56:1494-1502.
2013
-
Reduced Socs3 expression in adipose tissue protects female mice against obesity-induced insulin resistance.
55:3083-3093.
2012
-
What’s new since Hippocrates? Preventing type 2 diabetes by physical exercise and diet.
55:535-539.
2012
-
Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.
55:36-45.
2012
-
Voluntary physical activity and leucine correct impairments in muscle protein synthesis in partially pancreatectomised rats.
54:3111-3120.
2011
-
Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes.
54:487-495.
2011
-
Dysglycaemia, dyslipidaemia and hypertension: risk factors primarily focused on the disease or risk estimates primarily focused on the patient?.
54:230-232.
2011
-
Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study.
53:2509-2517.
2010
-
Anthropometric measures and glucose levels in a large multi-ethnic cohort of individuals at risk of developing type 2 diabetes.
53:1322-1330.
2010
-
Folic acid administration reduces neointimal thickening, augments neo-vasa vasorum formation and reduces oxidative stress in saphenous vein grafts from pigs used as a model of diabetes.
53:980-988.
2010
-
Erratum to: Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity.
53:398-398.
2010
-
Intensive glucose control and macrovascular outcomes in type 2 diabetes.
52:2288-2298.
2009
-
Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity.
52:2395-2404.
2009
-
Exercise intensity and insulin sensitivity: how low can you go?.
52:1709-1713.
2009
-
Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells.
50:2008-2018.
2007
-
Reply to comment on: Gerstein HC, Pogue J, Mann JFE et al. (2005) The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 48:1749–1755.
49:613-614.
2006
-
Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies.
48:2460-2469.
2005
-
Fetal and neonatal exposure to nicotine in Wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetes.
48:2661-2666.
2005
-
The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis.
48:1749-1755.
2005
-
Regulating adiponectin: of flax and flux.
48:1035-1037.
2005
-
Neonatal diabetes, with hypoplastic pancreas, intestinal atresia and gall bladder hypoplasia: search for the aetiology of a new autosomal recessive syndrome.
47:2160-2167.
2004
-
Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial.
47:1519-1527.
2004
-
40th EASD Annual Meeting of the European Association for the Study of Diabetes.
47:A1-A464.
2004
-
35th Annual Meeting of the European Association for the Study of Diabetes.
42:A1-A330.
1999
-
Streptozotocin-induced diabetes has differential effects on atrial natriuretic peptide synthesis in the rat atrium and ventricle: a study by solution-hybridization-RNase protection assay.
41:660-665.
1998
-
Immunocytochemical localization of heat-shock protein 60-related protein in Beta-cell secretory granules and its altered distribution in non-obese diabetic mice.
35:316-324.
1992
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)